Grey Wolf Animal Health Corp. (TSXV:WOLF)

Market Cap	30.77M
Revenue (ttm)	26.83M
Net Income (ttm)	704.67K
Shares Out	34.19M
EPS (ttm)	0.02
PE Ratio	45.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,000
Average Volume	8,375
Open	0.9000
Previous Close	0.9200
Day's Range	0.9000 - 0.9000
52-Week Range	0.6000 - 1.2000
Beta	0.34
RSI	36.13
Earnings Date	Apr 11, 2025

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics. It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, elastic bandages, and silicone perforated tapes, as w...

• Industry: Personal Services
• Sector: Consumer Discretionary
• CEO: Angela Cechetto
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WOLF

Financial Performance

In 2024, Grey Wolf Animal Health's revenue was 26.83 million, an increase of 5.58% compared to the previous year's 25.41 million. Earnings were 704,668, an increase of 15.60%.